3i Group 

€19.4
428
-€0.5-2.51% 今天

統計

當日最高
19.4
當日最低
19.4
52週最高
-
52週最低
-
成交量
0
平均成交量
-
市值
38.27B
市盈率
8.24
股息收益率
1.87%
股息
0.36

即將到來

股息

1.87%股息收益率
10年增長
11.73%
5年增長率
11.13%
3年增長率
15.17%
1年增長率
10.03%

收益

14Nov預期
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
下一個
0
1.21
2.43
3.64
預期每股收益
N/A
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 IGQ.F 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, cl
Show more...
首席執行官
Mr. Simon Alexander Borrows
員工
249
國家
US
ISIN
US88579N1054
WKN
000A0YG02

上市公司